5 Best Big Pharma Stocks to Buy Now

4. Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders: 67

Biopharmaceutical giant Pfizer Inc. (NYSE:PFE) ranks fourth on the list of 10 best big pharma stocks to buy now. The New York-based drug manufacturer sells medications and vaccines internationally. On September 20, Pfizer Inc. (NYSE:PFE) announced additional favorable results from a clinical study of its COVID-19 vaccine in children aged 5 to 11 years old. The COVID-19 vaccine produced by Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) appears to be safe and stimulate a strong immune response in children under the age of 12 years old, according to clinical study results.

On September 20, SVB Leerink analysts maintained a Market Perform rating on Pfizer Inc. (NYSE:PFE) with a price target of $50 per share. 

In the second quarter of 2021, Pfizer Inc. (NYSE:PFE) reported an EPS of $1.07, beating estimates by $0.09. The company’s second-quarter revenue came in at $18.98 billion and beat revenue estimates by $249.96 million. The stock has gained 19%, year to date.

At the end of the second quarter of 2021, 67 hedge funds in the database of Insider Monkey held stakes worth $2.35 billion in Pfizer Inc. (NYSE:PFE), down from 65 in the previous quarter worth $2.01 billion. 

Out of the hedge funds being tracked by Insider Monkey, Ohio-based hedge fund firm Diamond Hill Capital is a leading shareholder in Pfizer Inc. (NYSE:PFE) with 11,681,378 shares worth more than $457 million.